The Impact of COVID-19 on Nuclear Medicine in Europe.

COVID-19 Europe / epidemiology Humans Nuclear Medicine Pandemics SARS-CoV-2

Journal

Seminars in nuclear medicine
ISSN: 1558-4623
Titre abrégé: Semin Nucl Med
Pays: United States
ID NLM: 1264464

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 31 7 2021
medline: 15 12 2021
entrez: 30 7 2021
Statut: ppublish

Résumé

The COVID-19 pandemic has profoundly changed hospital activities, including nuclear medicine (NM) practice. This review aimed to determine and describe the impact of COVID-19 on NM in Europe and critically discuss actions and strategies applied to face the pandemic. A literature search for relevant articles was performed on PubMed, covering COVID-19 studies published up until January 21, 2021. The findings were summarized according to general and specific activities within the NM departments. The pandemic strongly challenged NM departments: a reduction in the workforce has been experienced in almost every center in Europe due to personnel diagnosed with COVID-19 and other reasons related to the coronavirus. NM departments introduced procedures to limit COVID-19 transmission, including environmental and personal hygiene, social distancing, rescheduling of non-high-priority procedures, the correct use of personal protective equipment, and prompt identification of suspect COVID-19 cases. A proportion of the departments experienced a delay in radiopharmaceuticals supply or technical assistance during the pandemic. Furthermore, the pandemic resulted in a significant reduction of diagnostic and therapeutic NM procedures, as well as a reduced level of care for patients affected by diseases other than COVID-19, such as cancer or acute cardiovascular disease. Telemedicine services have been set up to maintain medical assistance for patients. COVID-19 pandemic has reshaped human work resources, patient's diagnostic and therapeutic management, operative models, radiopharmaceutical supplies, teaching, training and research of NM departments. Limits of availability of resources emerged. Nonetheless, we have to provide continuity in care, especially for fragile patients, maintaining infection control measures. Challenges that have been faced should reshape our vision and get us prepared for the future.

Identifiants

DOI: 10.1053/j.semnuclmed.2021.06.022 PMID: 34325819 PMC: PMC8245351
pubmed: 34325819
pii: S0001-2998(21)00054-4
doi: 10.1053/j.semnuclmed.2021.06.022
pmc: PMC8245351
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-24

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1615-1619
pubmed: 32296886
Nucl Med Commun. 2021 Feb 1;42(2):138-149
pubmed: 33346606
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1628-1629
pubmed: 32333069
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2487-2492
pubmed: 32700058
J Endocrinol Invest. 2021 May;44(5):989-994
pubmed: 32803662
Hell J Nucl Med. 2020 May-Aug;23 Suppl:35-40
pubmed: 32860395
J Nucl Med. 2020 Sep;61(9):1278-1283
pubmed: 32709733
J Nucl Med Technol. 2020 Sep;48(3):227-233
pubmed: 32709668
Br J Hosp Med (Lond). 2020 Nov 2;81(11):1-9
pubmed: 33263482
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):831-836
pubmed: 32965559
J Thorac Oncol. 2020 Jun;15(6):1078-1080
pubmed: 32243920
J Nucl Cardiol. 2021 Feb;28(1):331-335
pubmed: 32737838
Clin Nucl Med. 2020 Nov;45(11):854-859
pubmed: 32796237
J Infect Dis. 2021 Jan 4;223(1):28-37
pubmed: 32986824
Hell J Nucl Med. 2020 May-Aug;23 Suppl:15-20
pubmed: 32860391
J Card Surg. 2020 Dec;35(12):3545-3550
pubmed: 33040399
Hell J Nucl Med. 2020 May-Aug;23 Suppl:26-30
pubmed: 32860393
Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):234
pubmed: 36149451
J Nucl Med. 2020 Aug;61(8):1094-1095
pubmed: 32576637
Healthcare (Basel). 2020 Nov 11;8(4):
pubmed: 33187343
Nucl Med Commun. 2021 Feb 1;42(2):127-137
pubmed: 33315728
Hell J Nucl Med. 2020 May-Aug;23 Suppl:41-50
pubmed: 32860396
Am J Med. 2021 Apr;134(4):482-489
pubmed: 33010226
Nuklearmedizin. 2020 Jun;59(3):276-280
pubmed: 32259853
J Nucl Med. 2020 May;61(5):626-629
pubmed: 32238430
Cell. 2020 Aug 20;182(4):790-793
pubmed: 32822570
Arch Cardiovasc Dis. 2020 Jun - Jul;113(6-7):374-377
pubmed: 32605783
Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2691-2697
pubmed: 32572561
Eur J Endocrinol. 2020 Jul;183(1):G41-G48
pubmed: 32438345
Eur J Nucl Med Mol Imaging. 2020 Jul;47(7):1634-1635
pubmed: 32198615
J Nucl Cardiol. 2020 Oct;27(5):1832-1833
pubmed: 32766999
Hell J Nucl Med. 2020 May-Aug;23 Suppl:31-34
pubmed: 32860394
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2066-2067
pubmed: 32548661
Nucl Med Commun. 2020 Sep;41(9):991-993
pubmed: 32796489
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2090-2099
pubmed: 32462398
Eur J Cancer. 2020 Dec;141:171-184
pubmed: 33161241
Hell J Nucl Med. 2020 May-Aug;23 Suppl:51-56
pubmed: 32860397
Eur Heart J. 2020 May 21;41(20):1872-1874
pubmed: 32391880
Nuklearmedizin. 2020 Aug;59(4):294-299
pubmed: 32344438
Radiol Oncol. 2020 Jul 29;54(3):329-334
pubmed: 32726291
Lancet. 2020 Apr 11;395(10231):1190-1191
pubmed: 32240625
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2054-2058
pubmed: 32533240
Hell J Nucl Med. 2020 May-Aug;23 Suppl:57-64
pubmed: 32862216
Hell J Nucl Med. 2020 May-Aug;23 Suppl:21-25
pubmed: 32860392
Eur Radiol. 2021 Jan;31(1):468-474
pubmed: 32780206
J Card Surg. 2021 Feb;36(2):782
pubmed: 33284475
Eur J Cancer. 2021 Feb;144:200-214
pubmed: 33370645
Nucl Med Commun. 2020 Jun;41(6):499-504
pubmed: 32304491
Eur J Nucl Med Mol Imaging. 2020 Aug;47(9):2048-2053
pubmed: 32367256

Auteurs

Margarita Kirienko (M)

Nuclear Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Silvi Telo (S)

Nuclear Medicine, DIMES, Alma Mater Studiorum University of Bologna, Bologna, Italy. Electronic address: silvi.telo@studio.unibo.it.

Roland Hustinx (R)

Université de Liège, Liège, Belgium.

Jamshed B Bomanji (JB)

University College London Hospitals NHS Foundation Trust, London, UK.

Arturo Chiti (A)

Department of Biomedical Sciences, Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy.

Stefano Fanti (S)

Nuclear Medicine, DIMES, Alma Mater Studiorum University of Bologna, Bologna, Italy; IRCCS Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

Recherchemedicale.com › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › The Impact of COVID-19 on Nuclear Medicine in Europe.
Recherchemedicale.com › Régions géographiques › Europe › The Impact of COVID-19 on Nuclear Medicine in Europe.
Recherchemedicale.com › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The Impact of COVID-19 on Nuclear Medicine in Europe.
Recherchemedicale.com › Professions de santé › Médecine › Radiologie › Médecine nucléaire › The Impact of COVID-19 on Nuclear Medicine in Europe.
Recherchemedicale.com › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › The Impact of COVID-19 on Nuclear Medicine in Europe.
Recherchemedicale.com › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › The Impact of COVID-19 on Nuclear Medicine in Europe.